Search
Descriptor English: Devazepide
Descriptor Spanish: Devazepida
Descriptor devacepida
Entry term(s) devazepida
devazepide
Scope note: Derivado de la benzodiazepina que actúa sobre el receptor de colecistocinina A (CCKA) y antagoniza los efectos fisiológicos y de comportamiento de la CCK-8 (SINCALIDA), tales como la estimulación pancreática y la inhibición de la alimentación.
Descriptor Portuguese: Devazepida
Descriptor French: Dévazépide
Entry term(s): L 364,718
L-364,718
L364,718
MK 329
MK-329
MK329
Tree number(s): D03.633.100.079.080.070.200
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D020109
Scope note: A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Hormone Antagonists
Registry Number: JE6P7QY7NH
CAS Type 1 Name: 1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-
Previous Indexing: Benzodiazepinones (1986-1998)
Public MeSH Note: 99; DEVAZEPIDE was indexed under BENZODIAZEPINONES 1986-98
History Note: 99; use DEVAZEPIDE (NM) 1986-98
DeCS ID: 33814
Unique ID: D020109
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1999/01/01
Date of Entry: 1998/06/10
Revision Date: 2016/05/28
Devazepide - Preferred
Concept UI M0029847
Scope note A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
Preferred term Devazepide
MK-329 - Narrower
Concept UI M0353444
Preferred term MK-329
Entry term(s) MK 329
MK329
L-364,718 - Narrower
Concept UI M0353443
Preferred term L-364,718
Entry term(s) L 364,718
L364,718



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey